- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Surufatinib plus Sintilimab
Total 5236 results
-
Innovent Biologics (Suzhou) Co. Ltd.TerminatedAdvanced or Metastatic Solid TumorsChina
-
HutchmedActive, not recruitingNeuroendocrine Tumours | Neuroendocrine Tumour of the Lung | Small Intestinal NETSpain, France, United States, United Kingdom, Norway, Germany, Italy
-
Hutchison Medipharma LimitedCompletedNeuroendocrine TumorsChina
-
Hutchison Medipharma LimitedCompletedTumorsUnited States, Italy
-
Tianjin Medical University Cancer Institute and...RecruitingPancreatic Carcinoma | Neuroendocrine Carcinoma | Neuroendocrine Tumor Grade 3China
-
Hutchison Medipharma LimitedCompletedNeuroendocrine TumorsChina
-
Hutchison Medipharma LimitedCompleted
-
Wuhan Union Hospital, ChinaNot yet recruitingUnresectable Advanced Solid Tumors | Biliary Tract Tumors, Gastric Cancer, Small Cell Lung CancerChina
-
Peking UniversityRecruitingNeuroendocrine NeoplasmChina
-
HutchmedActive, not recruitingNeuroendocrine Tumors | Non-hematologic MalignancyJapan
-
Zhejiang Cancer HospitalRecruitingBile Duct AdenocarcinomaChina
-
Sun Yat-sen UniversityRecruitingGastric AdenocarcinomaChina
-
Hutchison Medipharma LimitedCompletedBiliary Tract CancerChina
-
Hutchison Medipharma LimitedCompleted
-
Tianjin Medical University Cancer Institute and...RecruitingGastric Neuroendocrine CarcinomaChina
-
Sun Yat-sen UniversityRecruiting
-
Fudan UniversityRecruitingHigh-Risk Localized Soft Tissue SarcomaChina
-
Hutchison Medipharma LimitedCompleted
-
Sun Yat-sen UniversityNot yet recruitingNon Clear Cell Renal CarcinomaChina
-
Shanghai Changzheng HospitalCompletedColorectal Cancer | Immunotherapy | Sintilimab | First-line Treatment | Anlotinib | Chemo-free TherapyChina
-
West China HospitalNot yet recruiting
-
HutchmedBeiGeneActive, not recruitingSoft Tissue Sarcoma | Small Cell Lung Cancer | Gastric Cancer | Colorectal Cancer | Neuroendocrine Tumors | Metastatic Solid Tumor | Anaplastic Thyroid CancerUnited States
-
Shandong Cancer Hospital and InstituteRecruiting
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruiting
-
Sun Yat-sen UniversityRecruitingMetastatic | Adenocarcinoma of Small Intestine | Appendix CarcinomaChina
-
The First Hospital of Jilin UniversityRecruiting
-
Fudan UniversityCompletedEsophageal Squamous Cell CarcinomaChina
-
Hutchison Medipharma LimitedUnknownBiliary Tract CancerChina
-
Affiliated Cancer Hospital & Institute of Guangzhou...RecruitingAdvanced Non-Small Cell Lung CancerChina
-
The Affiliated Hospital of Xuzhou Medical UniversityRecruiting
-
Qilu Hospital of Shandong UniversityThe Affiliated Hospital of Qingdao University; Shandong Provincial Hospital... and other collaboratorsNot yet recruitingNeuroendocrine Tumor Grade 3
-
Qilu Hospital of Shandong UniversityNot yet recruiting
-
Hutchison Medipharma LimitedCompletedHealthyUnited States
-
Shanghai Ninth People's Hospital Affiliated to...RecruitingHead and Neck Cancers - Salivary GlandChina
-
Zhejiang UniversityRecruitingLocally Advanced Gastric CarcinomaChina
-
Shanghai Chest HospitalUnknownCarcinoma | Non-small Cell Lung Cancer
-
Changhai HospitalNot yet recruitingPancreatic Neuroendocrine TumorChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingColorectal Neoplasms MalignantChina
-
Fudan UniversityNot yet recruitingSoft Tissue Sarcoma Adult
-
Fudan UniversityRecruitingDifferentiated Thyroid CancerChina
-
HutchmedNo longer available
-
Sun Yat-sen UniversityRecruiting
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingHepatocellular CarcinomaChina
-
Sun Yat-sen UniversityRecruiting
-
Hutchison Medipharma LimitedCompleted
-
Nanfang Hospital of Southern Medical UniversityNot yet recruitingUnresectable Hepatocellular Carcinoma
-
Hutchison Medipharma LimitedCompleted
-
Shanghai Changzheng HospitalNot yet recruitingAdvanced Solid Tumors With Neuroendocrine Differentiation
-
Huihua XiongNot yet recruitingMetastatic Triple-negative Breast CancerChina
-
Peking Union Medical College HospitalNot yet recruitingEfficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients